Femoston Mini Tablet is a hormone replacement therapy medication containing estradiol (0.5 mg) and dydrogesterone (2.5 mg), designed to alleviate symptoms associated with menopause. Estradiol, a form of estrogen, helps to restore declining hormone levels in women experiencing menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings. Dydrogesterone, a synthetic progestogen, works alongside estradiol to protect the lining of the uterus (endometrium) from hyperplasia, which can occur with estrogen-only therapy. This combination helps maintain hormonal balance and reduces the risk of endometrial abnormalities. Femoston Mini is typically prescribed for women who have not undergone a hysterectomy and require continuous combined hormone replacement therapy. It is important to use this medication under medical supervision, as hormone therapy may carry risks including blood clots, stroke, and breast cancer, especially with long-term use. Patients should inform their healthcare provider about their medical history and any other medications they are taking. Femoston Mini Tablet is usually taken once daily, and adherence to prescribed dosage and regular follow-up appointments are essential to ensure safety and effectiveness in managing menopausal symptoms.